Advanced transgenic and gene-targeting approaches

Neurochemical Research

Volumn 24, Issue 9, 1999, Pages 1181-1188

  Gao, Xiang ^a   Kemper, April ^a   Popko, Brian ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Conditional gene targeting; Genetic manipulation; Inducible transgene expression

Indexed keywords

GAMMA INTERFERON; HEAVY METAL; METAL ION; STEROID RECEPTOR; TETRACYCLINE;

GENE CONTROL; GENE EXPRESSION SYSTEM; GENE INACTIVATION; GENE INDUCTION; GENE TARGETING; GENETIC ENGINEERING; GENETIC MANIPULATION; HEAT SHOCK; HUMAN; KNOCKOUT GENE; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TECHNIQUE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE EXPRESSION; GENE TARGETING; MICE; RECEPTORS, STEROID; TETRACYCLINE;

EID: 0032830909     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020772706279     Document Type: Review

References (53)

1. Capecchi, M. R. 1989. Altering the genome by homologous recombination. Science 244:1288-1292.
2. Smithies, O. 1993. Animal models of human genetic diseases. Trends Genet. 9:112-116.
3. Popko, B. 1999. An overview of mouse models in neuroscience research. Advances in Neurochemistry. Vol. 9, Pages 1-23, in Popko, B. (ed.), Mouse Models in the Study of Genetic Neurological Disorders, Klumer Academic/Plenum Publishers, New York.
4. Bruijn, L. I., and Cleveland, D. W. 1996. Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease. Neuropathol. Appl. Neurobiol. 22:373-387.
5. Huang, T. T., Yasunami, M., Carlson, E. J., Gillespie, A. M., Reaume, A. G., Hoffman, E. K., Chan, P. H., Scott, R. W., and Epstein, C. J. 1997. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 344: 424-432.
6. Copp, A. J. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87-93.
7. Thomas, J. H. 1993. Thinking about genetic redundancy. Trends Genet. 9:395-409.
8. Gingrich, J. R., and Roder, J. 1998. Inducible gene expression in the nervous system of transgenic mice. Annu. Rev. Neurosci. 21 : 377-405.
9. Saez, E., No, D., West, A., and Evans, R. M. 1997. Inducible gene expression in mammalian cells and transgenic mice. Curr. Opin. Biotechnol. 8:608-616.
10. Kothary, R., Clapoff, S., Darling, S., Perry, M. D., Moran, L. A., and Rossant, J. 1989. Inducible expression of an hsp68-1acZ hybrid gene in transgenic mice. Development 105:707-714.
11. Filmus, J., Remani, J., and Klein, M. H. 1992. Synergistic induction of promoters containing metal- and glucocorticoid-responsive elements. Nucleic Acids Res. 20:2755-2760.
12. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky. K. 1995. Inducible gene targeting in mice. Science 269:1427-1429.
13. Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S., and Meier, E. 1990. Transgenic mice with intracellular immunity to influenza virus. Cell 62:51-61.
14. Popko, B., Corbin, J. G., Baerwald, K. D., Dupree, J., and Garcia, A. M. 1997. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:19-35.
15. No, D., Yao, T. P., and Evans, R. M. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346-3351.
16. Yao, T. P., Segraves, W. A., Oro, A. E., McKeown, M., and Evans, R. M. 1992. Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell 71:63-72.
17. Suhr, S. T., Gil, E. B., Senut, M. C., and Gage, F. H. 1998. High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor. Proc. Natl. Acad. Sci. USA 95:7999-8004.
18. Burcin, M. M., O'Malley, B. W., and Tsai, S. Y. 1998. A regulatory system for target gene expression. Front Biosci. 3:1-7.
19. Wang, Y., DeMayo, F. J., Tsai, S. Y., and O'Malley, B. W. 1997. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnol. 15:239-243.
20. Gossen, M., and Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
21. Furth, P. A., St.-Onge, L., Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., and Hennighausen, L. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91:9302-9306.
22. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H., and Bujard, H. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93:10933-10938.
23. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
24. Yu, Z., Redfern, C. S., and Fishman, G. I. 1996. Conditional transgene expression in the heart. Circ. Res. 79:691-697.
25. Ray, P., Tang, W., Wang, P., Homer, R., Kuhn, C. 3rd., Flavell, R. A., and Elias, J. A. 1997. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J. Clin. Invest. 100:2501-2511.
26. Tremblay, P., Meiner, Z., Galou, M., Heinrich, C., Petromilli, C., Lisse, T., Cayetano, J., Torchia, M., Mobley, W., Bujard, H., DeArmond, S. J., and Prusiner, S. B. 1998. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc. Natl. Acad. Sci. USA 95:12580-12585.
27. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., and Koistinaho, J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. USA 95:15769-15774.
28. Baron, U., Gossen, M., and Bujard, H. 1997. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 25:2723-2729.
29. Mayford, M., Bach, M. E., Huang, Y. Y., Wang, L., Hawkins, R. D., and Kandel, E. R. 1996. Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678-1683.
30. Mansuy, I. M., Mayford, M., Jacob, B., Kandel, E. R., and Bach, M. E. 1998. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92:39-49.
31. Mansuy, I. M., Winder, D. G., Moallem, T. M., Osman, M., Mayford, M., Hawkins, R. D., and Kandel, E. R. 1998. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21:257-265.
32. Thomas, K. R., and Capecchi, M. R. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503-512.
33. Lakso, M., Saucer, B., Mosinger, B. J., Lee, E. J., Minning, R. W., Yu, S. H., Mulder, K. L., and Westphal, H. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89:6232-6236.
34. Orban, P. C., Chui, D., and Marth, J. D. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89:6861-6865.
35. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H., and Rajewsky, K. 1994. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265:103-106.
36. Chen, C., and Tonegawa, S. 1997. Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. Annu. Rev. Neurosci. 20:157-184.
37. Li, Y., Erzurumlu, R., Chen, C., Jhaveri, S., and Tonegawa, S. 1994. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-437.
38. Forrest, D., Yuzaki, M., Soares, H. D., Ng, L., Luk, D. C., Sheng, M., Stewart, C. L., Morgan, J. I., Conner, J. A., and Curran, T. 1994. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325-338.
39. Tsien, J. Z., Huerta, P. T., and Tonegawa, S. 1996. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338.
40. Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., and Tonegawa, S. 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326.
41. St.-Onge, L., Furth, P. A., and Gruss, P. 1996. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24:3875-3877.
42. Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods 14:381-392.
43. Metzger, D., Clifford, J., Chiba, H., and Chambon, P. 1995. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92:6991-6995.
44. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. 1996. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 93:10887-10890.
45. Zhang, Y., Riesterer, C., Ayrall, A. M., Sablitzky, F., Littlewood, T. D., and Reth, M. 1996. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 24:543-548.
46. Schwenk, F., Kuhn, R., Angrand, P. O., Rajewsky, K., and Stewart, A. F. 1998. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26:1427-1432.
47. Brocard, J., Feil, R., Chambon, P., and Metzger, D. 1998. A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res. 26: 4086-4090.
48. Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K., and McMahon, A. P. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8:1323-1326.
49. Valentijn, L. J., Bolhuis, P. A., Zorn, I., Hoogendijk, J. E., Van den Bosch, N., Hensels, G. W., Stanton, V. P. Jr., Housman, D. E., Fischbeck, K. H., Ross, D. A., Nicholson, G. A., Meershoek, E. J., Dauwerse, H. G., van Ommen, G. J. B., and Baas, F. 1992. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nature Genet. 1:166-170.
50. Ramirez-Soils, R., Liu, P., and Bradley, A. 1995. Chromosome engineering in mice. Nature 378:720-724.
51. Lewandoski, M., and Martin, G. R. 1997. Cre-mediated chromosome loss in mice. Nature Genet. 17:223-225.
52. Li, Z. W., Stark, G., Gotz, J., Rulicke, T., Gschwind, M., Huber, G., Muller, U., and Weissmann, C. 1996. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 93:6158-6162.
53. Drago, J., Padungchaichot, P., Wong, J. Y. F., Lawrance, A. J., McManus, J. F., Sumarsono, S. H., Natoli, A. L., Wreford, N., Westphal, H., Kola, I., and Finkelstein, D. I. 1998. Targeted expression of a toxin gene to D1 Dopamine receptor neurons by Cre mediated site-specific recombination. J. Neurosci. 18: 9845-9857.